• Business NewsBeta
  • Shows
    • Daily Show2+2=5Take it EasyRed AlertFormula GuruMoney GyanMoney CentralMoney timeJhatpat
    • Weekly ShowMoney ComicsEconomicomRealty CheckSmile and payMoney TalesSpend WiseCompanynama
  • Insurance
  • Savings
  • Loan
  • Stocks
  • Mutual Funds
  • Real Estate
  • Crypto
  • Tax
    • हिन्दी
    • తెలుగు
    • मराठी
    • বাংলা
    • ગુજરાતી
    • ಕನ್ನಡ
  • Close
Subscribe Follow

Share

  • Facebook
  • Twitter
  • Whatsapp
  • LinkedIn
  • Telegram
  • Daily Show
    • 2+2=5
    • Take it Easy
    • Red Alert
    • Formula Guru
    • Money Gyan
    • Money Central
    • Money time
    • Jhatpat
  • Weekly Show
    • Money Comics
    • Economicom
    • Realty Check
    • Smile and pay
    • Money Tales
    • Spend Wise
    • Companynama
  • Insurance
  • Savings
  • Loan
  • Crypto
  • Stocks
  • Mutual Funds
  • Real Estate
  • Tax
  • Exclusive
  • Home » News » Covid Update » Brazil suspends Bharat Biotech’s Covaxin order over graft allegations

Brazil suspends Bharat Biotech’s Covaxin order over graft allegations

The Covaxin contract to Brazil landed in controversy after the South American country's Attorney General reportedly launched a probe into the deal

  • Press Trust of India
  • Publish Date - June 30, 2021 / 01:55 PM IST
Brazil suspends Bharat Biotech's Covaxin order over graft allegations
The import duty waiver on importing raw materials used in manufacturing Covid kits will help people in fighting the pandemic

Hyderabad: The Brazilian government on Wednesday announced the temporary suspension of its 20 million dose Covid-19 vaccine contract with Bharat Biotech following allegations of irregularities in the deal, with the Indian drug maker insisting that it has not received any advance payments.

The city-based firm said it has not received any advance payments and that the company has followed a “similar approach” in Brazil towards contracts, regulatory approvals and supplies in several countries worldwide, where Covaxin is being supplied successfully.

Announcing the Brazil government’s decision, its Health Ministry said in a statement that “with the recommendation of the Office of the Comptroller General of the Union (CGU), the Ministry of Health temporarily suspended the contract for the purchase of Covid-19 vaccine from Covaxin this Tuesday (29).” “The measure does not affect the pace of the vaccination campaign to fight the pandemic in the country and follows compliance practices in public administration,” it said.

The contract was also evaluated by the Ministry of Health’s Integrity Directorate, which will carry out an administrative investigation.

The unit will act together with the “Controllership” in determining the terms of the contract, it further said.

Responding, Bharat Biotech said the company has not received any advance payments nor has it supplied any vaccines to Brazil.

“As of 29th June 2021, Bharat Biotech has not received any advance payments nor supplied any vaccines to MOH Brazil.” “Bharat Biotech has followed a similar approach towards contracts, regulatory approvals and supplies in several countries worldwide, where Covaxin is being supplied successfully,” it said in a statement.

Precisa Medicamentos is Bharat Biotech’s partner in Brazil, providing assistance, guidance and support with regulatory submissions, licensure, distribution, insurance, conduct of phase III clinical trials, etc.

The Covaxin contract to Brazil landed in controversy after the South American country’s Attorney General reportedly launched a probe into the deal.

The minister of the CGU, Wagner Rosrio, explained that the suspension is a preventive measure.

“We opened a preliminary investigation last week, that is, a specific audit in relation to the contract. The suspension time will only last for the period of calculation. We put the reinforced team to be very quick in the process,” he said. The CGU said it began a preliminary investigation into possible irregularities in the contracting of Covaxin on June 24.

“By recommendation of @CGUonline, we decided to temporarily suspend the Covaxin contract.” According to CGU’s preliminary analysis, there are no irregularities in the contract, but, due to compliance, the @minsaude opted to suspend the contract for further analysis,” Brazil Health Minister Marcelo Queiroga tweeted.

On February 26, Bharat Biotech Ltd had said it entered into an agreement with the Brazilian government for the supply of 20 million doses of Covaxin during the second and third quarters of 2021.

Earlier, the National Health Surveillance Agency of Brazil- Anvisa, had denied permission to import Covaxin under Emergency Use Authorisation after authorities found that the Indian plant in which the jab was being made did not meet the Good Manufacturing Practice (GMP) requirements.

However, Anvisa on June 5 gave clearance to the proposal to import Covaxin into the South American country, with some conditions.The Emergency Use Authorisation for Covaxin was granted by Brazil on June 4.

The pricing of Covaxin has been clearly established between $15-20 per dose for supplies to governments outside India. The pricing for Brazil has also been indicated at $15 per dose.

Bharat Biotech has received advance payments from several other countries at the above price points, with supplies in process, pending approvals, Bharat Biotech said.

The company follows a similar partnership model in all countries, where its vaccines are supplied, as it does not have its own offices there.

Bharat Biotech and Precisa Medicamentos are conducting a 5000-subject phase III clinical trial in Brazil, which was recently approved by Anvisa. The trial will be conducted by the Albert Einstein Institute, the vaccine maker said.

Download Money9 App for the latest updates on Personal Finance.

follow us

  • Facebook
  • Twitter
  • LinkedIn
  • Telegram
  • Youtube
  • Instagram

also read

  • Covid first wave led to increase in antibiotic misuse in India: Study

    Covid first wave led to increase in antibiotic misuse in India: Study

  • Centre rushes teams to six states reporting a high number of Covid cases

    Centre rushes teams to six states reporting a high number of Covid cases

Read more news on

  • Bharat Biotech
  • Brazil
  • Covaxin
  • Precisa Medicamentos
  • Vaccine Diplomacy

Latest Video

SEE MORE
What is target price for Nifty and Sensex?

What is target price for Nifty and Sensex?

Updated: June 28, 2022
Why wheat flour prices increased after wheat export ban?

Why wheat flour prices increased after wheat export ban?

Updated: June 27, 2022
Is Petrol-Diesel price increase again on the cards?

Is Petrol-Diesel price increase again on the cards?

Updated: June 23, 2022
Why are edible oil prices falling?

Why are edible oil prices falling?

Updated: June 23, 2022
Why popular AMC stocks are down?

Why popular AMC stocks are down?

Updated: June 22, 2022
Why are car, two wheeler prices not falling?

Why are car, two wheeler prices not falling?

Updated: June 21, 2022
IRDA bats for reforms in the insurance sector

IRDA bats for reforms in the insurance sector

Updated: June 20, 2022
Should you invest in Gold when stock market is falling?

Should you invest in Gold when stock market is falling?

Updated: June 19, 2022
Open in App

Related

  • Covaxin for children likely to be rolled out in phases: Report

    Covaxin for children likely to be rolled out in phases: Report

  • Covaxin gets emergency use approval for kids aged 2-18 years

    Covaxin gets emergency use approval for kids aged 2-18 years

  • Indian students can travel to Australia as Covishield get approval down under

    Indian students can travel to Australia as Covishield get approval down under

  • Phase 2 and 3 trials of Bharat Biotech’s paediatric Covaxin completed

    Phase 2 and 3 trials of Bharat Biotech’s paediatric Covaxin completed

  • Covid vaccine export to be resumed from October: Union health minister Mansukh Mandaviya

    Covid vaccine export to be resumed from October: Union health minister Mansukh Mandaviya

  • COVAX cuts delivery target by 25% due to supply constraints

    COVAX cuts delivery target by 25% due to supply constraints

Videos

  • GST Council may reduce tax on orthopedic, ostomy appliances, etc
    Exclusive

    FPI buying may resume in coming 1-2 quarters

  • Is Petrol-Diesel price increase again on the cards?
    Budget

    Is Petrol-Diesel price increase again on the cards?

  • Complaint process on loan recovery agent harassment
    Loan

    Complaint process on loan recovery agent harassment

  • Will buy stocks in India if Nifty drops to 14,000: Christopher Wood
    Exclusive

    PNB, UBI turn ex-dividend

  • Why are edible oil prices falling?
    Exclusive

    Why are edible oil prices falling?

  • TV9 Sites

  • TV9 Hindi
  • TV9Telugu.com
  • TV9 Marathi
  • TV9 Gujarati
  • TV9 Kannada
  • TV9 Bangla
  • News9 Live
  • Know this india
  • Money9 Sites

  • Money9 Hindi
  • Money9 English
  • Money9 Marathi
  • Money9 Telugu
  • Money9 Gujarati
  • Money9 Kannada
  • Money9 Bangla
  • Topics

  • Insurance
  • Savings
  • Loan
  • Stocks
  • Mutual Funds
  • Real Estate
  • Tax
  • Crypto
  • Exclusive
  • Daily Shows

  • 2+2=5
  • Take it Easy
  • Red Alert
  • Formula Guru
  • Money Gyan
  • Money Central
  • Jhatpat
  • Money time
  • Weekly Shows

  • Money Comics
  • Economicom
  • Realty Check
  • Smile and pay
  • Money Tales
  • Companynama
  • Spend Wise
  • Follow us

  • FaceBook
  • Twitter
  • Youtube
  • Instagram
  • Linkedin
  • Download App

  • Andorid
  • ios
  • Contact Us
  • About Us
  • Advertise With Us
  • Privacy & Cookies Notice
  • Complaint Redressal
  • Copyright © 2022 Money9. All rights reserved.